Independent Sector Cancer Network (ISCN) Publish NEW Cancer Service Guidelines

The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the Independent Sector Cancer Services within the UK.

The ISCN is comprised of expert members who are senior leaders in cancer care, representing nursing, therapeutic radiology, and pharmacy. Over the past years, our team has diligently worked on developing these guidelines to be implemented across the independent sector, aiming to standardise and elevate clinical practice. Although led by the ISCN, this document has transferability to all cancer services.

The ISCN Cancer Service Guidelines 2024 are now readily available for use. These guidelines are designed to:

  • Guide quality of care in practice: Providing a comprehensive framework to ensure the highest standards of patient care.
  • Offer a benchmarking framework: Enabling teams to measure and compare their practices against established standards.
  • Standardize clinical practice: Ensuring consistency and excellence in cancer care across the independent sector.

The ISCN believes these guidelines will significantly contribute to improving patient outcomes and fostering a culture of continuous improvement in cancer care. The ISCN would encourage all teams to integrate these guidelines into their daily practice and use them as a tool for achieving excellence in patient care.

To access the guidelines please click here: https://www.bopa.org.uk/resources/iscn-cancer-service-guidelines/

Please note you need to be a free or paid member of BOPA to access.

Thank you for your commitment to advancing cancer care.

Best regards,
Independent Sector Cancer Network (ISCN)

Latest News

By BOPA on 2nd April 2026

BOPA welcomes Royal Pharmaceutical Society appointment of Justine Scanlan as Director of Pharmacy

The Royal Pharmaceutical Society (RPS) today (2nd April 2026) announced the appointment of Dr Justine Scanlan FRPharmS as its new Director of Pharmacy, a key leadership role as the organisation…

Read article
By BOPA Research Subcommittee on 30th March 2026

Abstract Submission for #BOPA2026 is NOW OPEN

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN     Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By Caoimhe Keenan on 29th March 2026

BOPA Education and Training Webinar: Clinical AI in the NHS

Helena Langford is a Fellow in Clinical AI and a Clinical Informatics Pharmacist at University Hospitals Bristol and Weston NHS Foundation Trust, with several years of experience in clinical informatics.…

Read article
By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article